Skip to main content

Navigation group

Type at least 3 characters

4 articles

No matches to your query could be found. Try another search term.
No matches to your query could be found. Try another search term.

Articles

Original Research

Published on 13 May 2024

Progressive multifocal leukoencephalopathy reports in rheumatoid arthritis concerning different treatment patterns-an exploratory assessment using the food and drug administration adverse event reporting system

in Rheumatic Drug Safety

Takeshi Honma
Kenji Onda
Koichi Masuyama

Progressive multifocal leukoencephalopathy reports in rheumatoid arthritis concerning different treatment patterns-an exploratory assessment using the food and drug administration adverse event reporting system

Frontiers in Drug Safety and Regulation

doi 10.3389/fdsfr.2024.1334468

861 views
1 citation

Mini Review

Published on 16 Feb 2023

Balancing the evidence: An update on analgesic use in rheumatic and musculoskeletal diseases

in Rheumatic Drug Safety

Yun-Ting Huang
Craig McCarthy
Meghna Jani

Balancing the evidence: An update on analgesic use in rheumatic and musculoskeletal diseases

Frontiers in Drug Safety and Regulation

doi 10.3389/fdsfr.2023.1117674

1,896 views
1 citation

Original Research

Published on 09 Jan 2023

Adverse events in rheumatoid arthritis patients under antimalarial treatment—Is there cardiovascular compromise?

in Rheumatic Drug Safety

Pedro Santos-Moreno
Linda Ibatá
Susan Martínez
Gabriel-Santiago Rodríguez-Vargas
Laura Villarreal
Pedro Rodríguez
Wilberto Rivero
Fernando Rodríguez-Florido
Adriana Rojas-Villarraga

Adverse events in rheumatoid arthritis patients under antimalarial treatment—Is there cardiovascular compromise?

Frontiers in Drug Safety and Regulation

doi 10.3389/fdsfr.2022.1044696

1,476 views

Specialty Grand Challenge

Published on 05 Apr 2022

Current Status and Future Challenges in the Treatment of Rheumatic Diseases

in Rheumatic Drug Safety

Enrique R. Soriano

Frontiers in Drug Safety and Regulation

doi 10.3389/fdsfr.2022.881556

3,500 views
5 citations